The school offers multidisciplinary training on multiscale approaches to the study of neurodevelopmental disorders, starting from the patient and integrating in vitro, in vivo, and computational models. The goal is to show how these different levels contribute to understanding pathological mechanisms and to the development of personalized therapies.
Guiding questions:
• How can we move from the laboratory to the patient?
• How can experimental discoveries be translated into effective therapies?

The school “Bridge the Gap: Multiscale Approaches in Neurodevelopmental Disorders” aims to address the challenges associated with neuropsychiatric and neurological diseases. The program will focus on the design and use of patient-derived models, in vivo platforms, and the growing importance of digital twins to predict personalized therapeutic responses.